Ellen de Brabander - 01 Apr 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Reporting relationship: Executive Vice President, Research, Development and Regulatory Affairs
Issuer ticker: ELAN
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Apr 2026, 16:30:20 UTC
Prior SEC filing: 12 Mar 2026
Next SEC filing: 12 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander

Key filing fact

Ellen de Brabander filed Form 4 for Elanco Animal Health Inc (ELAN) on 07 Apr 2026.

Key facts

This page summarizes Ellen de Brabander's Form 4 filing for Elanco Animal Health Inc (ELAN).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 Apr 2026, 16:30.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001892179 Primary reporting owner

Relationship: Executive Vice President, Research, Development and Regulatory Affairs
Address: C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Ellen de Brabander
Signature date: 07 Apr 2026

Shares, units, or other non-derivative securities reported in this filing.

ELAN transaction

Award

ELAN transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

SEC remarks

Executive Vice President, Research, Development and Regulatory Affairs